Funding for this research was provided by:
ministry of science and technology of the people's republic of china (2018YFA0507402)
National Natural Science Foundation of China (82041015, 32100123, 32100751)
postdoctoral science foundation of jiangsu province (NO.2020T130120ZX)
shanghai key infectious disease project (shslczdzk01102)
the special project for medical research innovation of 2020 shanghai “science and technology innovation action plan” (No.20Z11900900)
Received: 8 July 2021
Accepted: 30 September 2021
First Online: 14 October 2021
: The study was approved by the ethics committee of the Shanghai Public Health Clinical Center (2020-Y113-01). Procedures were conducted in accordance with the principles of the Helsinki Declaration. Written informed consent was obtained from all eligible participants.
: Not applicable
: The authors declare that they have no competing interests.